The U.S. healthcare industry continues to grow steadily, fueled by the continued aging of the U.S population, coupled with the desire for improved quality of care. Despite this growth, healthcare companies have seen a period of volatility due to changes in government and market regulations.
Drawing on the industry experience of global healthcare head Karen Bechtel, Carlyle sees opportunity in those companies that are able to adapt most rapidly to this dynamic environment. “Against this demographic and regulatory backdrop, Carlyle sees significant opportunity,” says Bechtel. “At the same time, the current indifference of the public markets to healthcare providers should create opportunities to acquire assets at attractive valuations.”
Through both buyout and venture funding, Carlyle invests in undervalued companies led by seasoned management that hold a competitive edge in the dynamic healthcare industry.
